A citation-based method for searching scientific literature

A Frustaci, J Kajstura, C Chimenti, I Jakoniuk, A Leri, A Maseri, B Nadal-Ginard, P Anversa. Circ Res 2000
Times Cited: 607







List of co-cited articles
1072 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


New type of cardiomyopathy associated with diabetic glomerulosclerosis.
S Rubler, J Dlugash, Y Z Yuceoglu, T Kumral, A W Branwood, A Grishman. Am J Cardiol 1972
30

Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway.
Lu Cai, Wei Li, Guangwu Wang, Luping Guo, Youchun Jiang, Y James Kang. Diabetes 2002
491
26

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.
Guanghong Jia, Vincent G DeMarco, James R Sowers. Nat Rev Endocrinol 2016
348
25

Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
Guanghong Jia, Michael A Hill, James R Sowers. Circ Res 2018
572
25

Molecular mechanisms of diabetic cardiomyopathy.
Heiko Bugger, E Dale Abel. Diabetologia 2014
479
23

Diabetic cardiomyopathy revisited.
Sihem Boudina, E Dale Abel. Circulation 2007
21

Role of diabetes in congestive heart failure: the Framingham study.
W B Kannel, M Hjortland, W P Castelli. Am J Cardiol 1974
18

Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.
Karina Huynh, Bianca C Bernardo, Julie R McMullen, Rebecca H Ritchie. Pharmacol Ther 2014
331
18

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
17

Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice.
Karina Huynh, Helen Kiriazis, Xiao-Jun Du, Jane E Love, Stephen P Gray, Karin A Jandeleit-Dahm, Julie R McMullen, Rebecca H Ritchie. Free Radic Biol Med 2013
94
14

Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice.
Zhonglin Xie, Kai Lau, Bonnie Eby, Pedro Lozano, Chaoyong He, Becky Pennington, Hongliang Li, Shradha Rathi, Yunzhou Dong, Rong Tian,[...]. Diabetes 2011
347
14

Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism.
Dirk Westermann, Susanne Rutschow, Sebastian Jäger, Anne Linderer, Stefan Anker, Alexander Riad, Thomas Unger, Heinz-Peter Schultheiss, Matthias Pauschinger, Carsten Tschöpe. Diabetes 2007
188
13


Cell death and diabetic cardiomyopathy.
Lu Cai, Y James Kang. Cardiovasc Toxicol 2003
130
13

Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.
Guanghong Jia, Adam Whaley-Connell, James R Sowers. Diabetologia 2018
259
13

Impact of diabetes on cardiac structure and function: the strong heart study.
R B Devereux, M J Roman, M Paranicas, M J O'Grady, E T Lee, T K Welty, R R Fabsitz, D Robbins, E R Rhoades, B V Howard. Circulation 2000
641
13

Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.
Zhi You Fang, Johannes B Prins, Thomas H Marwick. Endocr Rev 2004
661
12

Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart.
Ethan J Anderson, Alan P Kypson, Evelio Rodriguez, Curtis A Anderson, Eric J Lehr, P Darrell Neufer. J Am Coll Cardiol 2009
262
12

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
11

Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice.
Kimberley M Mellor, James R Bell, Morag J Young, Rebecca H Ritchie, Lea M D Delbridge. J Mol Cell Cardiol 2011
135
11

Diabetic cardiomyopathy, causes and effects.
Sihem Boudina, Evan Dale Abel. Rev Endocr Metab Disord 2010
451
11

Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy.
Thomas H Marwick, Rebecca Ritchie, Jonathan E Shaw, David Kaye. J Am Coll Cardiol 2018
137
11

Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II- dependent.
F Fiordaliso, B Li, R Latini, E H Sonnenblick, P Anversa, A Leri, J Kajstura. Lab Invest 2000
236
10

Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.
Sophie Van Linthout, Ute Seeland, Alexander Riad, Oleg Eckhardt, Mathias Hohl, Nasser Dhayat, Utz Richter, Jens W Fischer, Michael Böhm, Matthias Pauschinger,[...]. Basic Res Cardiol 2008
136
10

Increased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathways.
Ethan J Anderson, Evelio Rodriguez, Curtis A Anderson, Kathleen Thayne, W Randolph Chitwood, Alan P Kypson. Am J Physiol Heart Circ Physiol 2011
96
10

Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy.
Xia Shen, Shirong Zheng, Naira S Metreveli, Paul N Epstein. Diabetes 2006
273
10

Diminished autophagy limits cardiac injury in mouse models of type 1 diabetes.
Xianmin Xu, Satoru Kobayashi, Kai Chen, Derek Timm, Paul Volden, Yuan Huang, James Gulick, Zhenyu Yue, Jeffrey Robbins, Paul N Epstein,[...]. J Biol Chem 2013
163
10

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
9


Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.
T Nishikawa, D Edelstein, X L Du, S Yamagishi, T Matsumura, Y Kaneda, M A Yorek, D Beebe, P J Oates, H P Hammes,[...]. Nature 2000
9

Advanced glycation end products: sparking the development of diabetic vascular injury.
Alison Goldin, Joshua A Beckman, Ann Marie Schmidt, Mark A Creager. Circulation 2006
9

Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins.
Sihem Boudina, Sandra Sena, Heather Theobald, Xiaoming Sheng, Jordan J Wright, Xia Xuan Hu, Salwa Aziz, Josie I Johnson, Heiko Bugger, Vlad G Zaha,[...]. Diabetes 2007
411
9


Collagen remodelling in myocardia of patients with diabetes.
M Shimizu, K Umeda, N Sugihara, H Yoshio, H Ino, R Takeda, Y Okada, I Nakanishi. J Clin Pathol 1993
154
9

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
8

Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy.
Zoltán V Varga, Zoltán Giricz, Lucas Liaudet, György Haskó, Peter Ferdinandy, Pál Pacher. Biochim Biophys Acta 2015
196
8

Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy.
Yanli Zhao, Lina Zhang, Yu Qiao, Xiaoling Zhou, Guodong Wu, Lujing Wang, Yahui Peng, Xingli Dong, Hui Huang, Lining Si,[...]. PLoS One 2013
99
8

Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes.
Gang Ye, Naira S Metreveli, Rajakumar V Donthi, Shen Xia, Ming Xu, Edward C Carlson, Paul N Epstein. Diabetes 2004
199
8

MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy.
X Li, N Du, Q Zhang, J Li, X Chen, X Liu, Y Hu, W Qin, N Shen, C Xu,[...]. Cell Death Dis 2014
191
8

Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes.
Manuela Aragno, Raffaella Mastrocola, Claudio Medana, Maria Graziella Catalano, Ilenia Vercellinatto, Oliviero Danni, Giuseppe Boccuzzi. Endocrinology 2006
89
8

Apoptosis in patients with dilated cardiomyopathy and diabetes: a feature of diabetic cardiomyopathy?
F Kuethe, H H Sigusch, S R Bornstein, K Hilbig, V Kamvissi, H R Figulla. Horm Metab Res 2007
65
12

Diabetic cardiomyopathy: pathophysiology and clinical features.
Takayuki Miki, Satoshi Yuda, Hidemichi Kouzu, Tetsuji Miura. Heart Fail Rev 2013
284
8

Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart.
Sihem Boudina, Heiko Bugger, Sandra Sena, Brian T O'Neill, Vlad G Zaha, Olesya Ilkun, Jordan J Wright, Pradip K Mazumder, Eric Palfreyman, Timothy J Tidwell,[...]. Circulation 2009
205
8

Genetic loss of insulin receptors worsens cardiac efficiency in diabetes.
Heiko Bugger, Christian Riehle, Bharat Jaishy, Adam R Wende, Joseph Tuinei, Dong Chen, Jamie Soto, Karla M Pires, Sihem Boudina, Heather A Theobald,[...]. J Mol Cell Cardiol 2012
47
17

Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes.
Xia Shen, Shirong Zheng, Visith Thongboonkerd, Ming Xu, William M Pierce, Jon B Klein, Paul N Epstein. Am J Physiol Endocrinol Metab 2004
193
8


Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes.
K Huynh, H Kiriazis, X-J Du, J E Love, K A Jandeleit-Dahm, J M Forbes, J R McMullen, R H Ritchie. Diabetologia 2012
95
8

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
8

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
7

Glycemic control and heart failure among adult patients with diabetes.
C Iribarren, A J Karter, A S Go, A Ferrara, J Y Liu, S Sidney, J V Selby. Circulation 2001
479
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.